Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126070161 | 12607016 | 1 | I | 2007 | 20110801 | 20160729 | 20160729 | EXP | US-PFIZER INC-2011225506 | PFIZER | 77.00 | YR | F | Y | 0.00000 | 20160729 | OT | CN | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126070161 | 12607016 | 1 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, ONCE WEEKLY | N | 1023260 | 0 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | /wk | ||||
| 126070161 | 12607016 | 2 | SS | ENBREL | ETANERCEPT | 1 | 50 MG, WEEKLY | N | 0 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | /wk | ||||||
| 126070161 | 12607016 | 3 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | UNK | U | UNK | 11719 | ||||||||
| 126070161 | 12607016 | 4 | SS | PROLIA | DENOSUMAB | 1 | UNK | U | 0 | SOLUTION FOR INJECTION | |||||||||
| 126070161 | 12607016 | 5 | SS | PROLIA | DENOSUMAB | 1 | Unknown | UNK | U | UNK | 0 | SOLUTION FOR INJECTION | |||||||
| 126070161 | 12607016 | 6 | SS | FOSAMAX | ALENDRONATE SODIUM | 1 | UNK | U | 0 | ||||||||||
| 126070161 | 12607016 | 7 | SS | FOSAMAX | ALENDRONATE SODIUM | 1 | Unknown | UNK | U | UNK | 0 | ||||||||
| 126070161 | 12607016 | 8 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | UNK | U | UNK | 0 | ||||||||
| 126070161 | 12607016 | 9 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, FREQ:1 WEEK; INTERVAL: 1 | U | 1023260 | 0 | 50 | MG | ||||||
| 126070161 | 12607016 | 10 | SS | ENBREL | ETANERCEPT | 1 | 50 MG, FREQ:1 WEEK; INTERVAL: 1 | U | 1023260 | 0 | 50 | MG | |||||||
| 126070161 | 12607016 | 11 | C | PREDNISONE. | PREDNISONE | 1 | UNK | 0 | |||||||||||
| 126070161 | 12607016 | 12 | C | MEDROL | METHYLPREDNISOLONE | 1 | UNK | UNK | 0 | ||||||||||
| 126070161 | 12607016 | 13 | C | CALCIUM | CALCIUM | 1 | UNK | 0 | |||||||||||
| 126070161 | 12607016 | 14 | C | MAGNESIUM | MAGNESIUM | 1 | UNK | 0 | |||||||||||
| 126070161 | 12607016 | 15 | C | CORTISONE | CORTISONEHYDROCORTISONE | 1 | UNK | 0 | |||||||||||
| 126070161 | 12607016 | 16 | C | CORTISONE | CORTISONEHYDROCORTISONE | 1 | UNK | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126070161 | 12607016 | 1 | Rheumatoid arthritis |
| 126070161 | 12607016 | 2 | Ankylosing spondylitis |
| 126070161 | 12607016 | 3 | Ankylosing spondylitis |
| 126070161 | 12607016 | 4 | Product used for unknown indication |
| 126070161 | 12607016 | 6 | Product used for unknown indication |
| 126070161 | 12607016 | 8 | Ankylosing spondylitis |
| 126070161 | 12607016 | 9 | Ankylosing spondylitis |
| 126070161 | 12607016 | 10 | Rheumatoid arthritis |
| 126070161 | 12607016 | 11 | Product used for unknown indication |
| 126070161 | 12607016 | 12 | Product used for unknown indication |
| 126070161 | 12607016 | 13 | Product used for unknown indication |
| 126070161 | 12607016 | 14 | Product used for unknown indication |
| 126070161 | 12607016 | 16 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126070161 | 12607016 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126070161 | 12607016 | Arthralgia | |
| 126070161 | 12607016 | Arthritis | |
| 126070161 | 12607016 | Arthropathy | |
| 126070161 | 12607016 | Back pain | |
| 126070161 | 12607016 | Bladder disorder | |
| 126070161 | 12607016 | Blood urine present | |
| 126070161 | 12607016 | Bone density abnormal | |
| 126070161 | 12607016 | Cough | |
| 126070161 | 12607016 | Drug effect incomplete | |
| 126070161 | 12607016 | Fall | |
| 126070161 | 12607016 | Gait disturbance | |
| 126070161 | 12607016 | Injection site erythema | |
| 126070161 | 12607016 | Injection site mass | |
| 126070161 | 12607016 | Injection site pain | |
| 126070161 | 12607016 | Injection site pruritus | |
| 126070161 | 12607016 | Injection site reaction | |
| 126070161 | 12607016 | Injection site warmth | |
| 126070161 | 12607016 | Joint range of motion decreased | |
| 126070161 | 12607016 | Joint swelling | |
| 126070161 | 12607016 | Joint warmth | |
| 126070161 | 12607016 | Knee deformity | |
| 126070161 | 12607016 | Malaise | |
| 126070161 | 12607016 | Micturition urgency | |
| 126070161 | 12607016 | Musculoskeletal discomfort | |
| 126070161 | 12607016 | Oesophageal disorder | |
| 126070161 | 12607016 | Osteoporosis | |
| 126070161 | 12607016 | Pain | |
| 126070161 | 12607016 | Sinus disorder | |
| 126070161 | 12607016 | Sinusitis | |
| 126070161 | 12607016 | Sleep apnoea syndrome | |
| 126070161 | 12607016 | Spider vein | |
| 126070161 | 12607016 | Swelling | |
| 126070161 | 12607016 | Tooth disorder | |
| 126070161 | 12607016 | Vascular rupture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126070161 | 12607016 | 1 | 20020101 | 0 | ||
| 126070161 | 12607016 | 2 | 20140712 | 0 | ||
| 126070161 | 12607016 | 9 | 20020101 | 0 | ||
| 126070161 | 12607016 | 10 | 20140712 | 0 |